Dr. Lal Path Labs539524Diagnostics, healthcare
Dr Lal PathLabs completed acquisition of the remaining 30% stake in Suburban Diagnostics (Straterpath Labs) at over Rs 1,600 per share
By ScoutQuest · · 1 min read
- Stake acquired
- 30 percent
- Acquisition price per share
- 1600 rupees
Heard on business television between 07:47:22 - 07:50:22 IST.
- Company bought the remaining 30% stake in the diagnostics business at a price just above Rs 1,600 per share.
- The acquisition is now complete, closing this chapter for the company.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Dr. Lal PathLabs
Dr. Lal PathLabs: PathLabs Unifiers buys remaining 30% of Centrapath Labs at INR 1608.352 per share, CPL now wholly owned
13 Oct 2026
Dr. Lal PathLabs invests up to INR 30.3 crore in WOS PathLabs Unifiers to fund buyout of remaining 30% of CentraPath Labs
12 Oct 2026
Income Tax Dept appeals before ITAT against relief on ESOP expense disallowance
8 Oct 2026
Source: Live TV News Channel · 14 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.